ERIKA WALSH: Open Payments
NPI 1831689595 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$758 in 35 payments from 10 companies in 2025. Trend: 2023 $833 · 2024 $697 · 2025 $758
Food & beverage: $659Education: $99
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 7 | $232 |
| MAYNE PHARMA COMMERCIAL LLC | 12 | $195 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $57 |
| ABBVIE INC. | 2 | $51 |
| Biogen, Inc. | 3 | $48 |
| CooperSurgical, Inc. | 2 | $45 |
| Sumitomo Pharma America, Inc. | 2 | $44 |
| Exeltis, USA Inc. | 2 | $35 |
| Organon LLC | 1 | $29 |
| Pacira Pharmaceuticals Incorporated | 1 | $23 |
Products named: Veozah, ZURZUVAE, Paragard T 380A, Mirena, SLYND, NEXPLANON, LO LOESTRIN FE, LILETTA.
Industry payments across TX — which companies pay providers there.
